Quarterly ResultMay 5, 2026, 04:22 PM
Ardent Health Q1 Revenue $1.60B, Adjusted EBITDA $124M
AI Summary
Ardent Health, Inc. announced its first quarter 2026 financial results, reporting a 7.0% year-over-year increase in total revenue to $1.60 billion and a 26.3% rise in Adjusted EBITDA to $124 million. Net income attributable to Ardent Health was $40 million, or $0.28 per diluted share. Despite a 1.1% decrease in total admissions due to severe weather and a lighter respiratory season, adjusted admissions grew by 2.0%. The company reaffirmed its full-year 2026 financial guidance, citing strong execution and effective cost management, including $55 million in anticipated savings from its IMPACT program.
Key Highlights
- Total revenue grew 7.0% Y/Y to $1.60 billion.
- Adjusted EBITDA increased 26.3% Y/Y to $124 million.
- Net income attributable to Ardent Health was $40 million ($0.28 diluted EPS).
- Adjusted admissions increased 2.0% Y/Y to 86,244.
- Total surgeries grew 1.2% Y/Y to 31,342.
- Reaffirmed full-year 2026 revenue guidance: $6.40 billion - $6.70 billion.
- Reaffirmed full-year 2026 Adjusted EBITDA guidance: $485 million - $535 million.
- Net leverage ratio improved to 1.0x as of March 31, 2026.